Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
The increasing prevalence of metabolic syndrome-related diseases, including type-2 diabetes and obesity, makes it urgent to develop new alternative therapies, such as probiotics. In this study, we have used Caenorhabditis elegans under a high-glucose condition as a model to examine the potential pro...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Universidad de Navarra |
| Repositorio: | Dadun. Depósito Académico Digital de la Universidad de Navarra |
| Idioma: | inglés |
| OAI Identifier: | oai:dadun.unav.edu:10171/116690 |
| Acceso en línea: | https://hdl.handle.net/10171/116690 |
| Access Level: | acceso abierto |
| Palabra clave: | Caenorhabditis elegans Daf-16 Diabetes Insulin-signaling-pathway Obesity Probiotic β-oxidation. |
| id |
ES_3939ca7e9e2e44b5f63f6ce61c4e3f08 |
|---|---|
| oai_identifier_str |
oai:dadun.unav.edu:10171/116690 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724ebAyo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395aCaenorhabditis elegansDaf-16DiabetesInsulin-signaling-pathwayObesityProbioticβ-oxidation.The increasing prevalence of metabolic syndrome-related diseases, including type-2 diabetes and obesity, makes it urgent to develop new alternative therapies, such as probiotics. In this study, we have used Caenorhabditis elegans under a high-glucose condition as a model to examine the potential probiotic activities of Pediococcusacidilactici CECT9879 (pA1c). The supplementation with pA1c reduced C. elegans fat accumulation in a nematode growth medium (NGM) and in a high-glucose (10 mM) NGM medium. Moreover, treatment with pA1c counteracted the effect of the high glucose by reducing reactive oxygen species by 20%, retarding the aging process and extending the nematode median survival (>2 days in comparison with untreated control worms). Gene expression analyses demonstrated that the probiotic metabolic syndrome-alleviating activities were mediated by modulation of the insulin/IGF-1 signaling pathway (IIS) through the reversion of the glucose-nuclear-localization of daf-16 and the overexpression of ins-6 and daf-16 mediators, increased expression of fatty acid (FA) peroxisomal β-oxidation genes, and downregulation of FA biosynthesis key genes. Taken together, our data suggest that pA1c could be considered a potential probiotic strain for the prevention of the metabolic syndrome-related disturbances and highlight the use of C. elegans as an appropriate in vivo model for the study of the mechanisms underlying these diseases.MDPIDadun. Depósito Académico Digital Universidad de Navarra20222022-01-0120222022-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/116690reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/1166902026-06-21T12:47:57Z |
| dc.title.none.fl_str_mv |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) |
| title |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) |
| spellingShingle |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98 Caenorhabditis elegans Daf-16 Diabetes Insulin-signaling-pathway Obesity Probiotic β-oxidation. |
| title_short |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) |
| title_full |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) |
| title_fullStr |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) |
| title_full_unstemmed |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) |
| title_sort |
Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS) |
| dc.creator.none.fl_str_mv |
Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98 Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724eb Ayo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5 Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1 Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395a |
| author |
Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98 |
| author_facet |
Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98 Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724eb Ayo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5 Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1 Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395a |
| author_role |
author |
| author2 |
Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724eb Ayo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5 Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1 Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395a |
| author2_role |
author author author author |
| dc.contributor.none.fl_str_mv |
Dadun. Depósito Académico Digital Universidad de Navarra |
| dc.subject.none.fl_str_mv |
Caenorhabditis elegans Daf-16 Diabetes Insulin-signaling-pathway Obesity Probiotic β-oxidation. |
| topic |
Caenorhabditis elegans Daf-16 Diabetes Insulin-signaling-pathway Obesity Probiotic β-oxidation. |
| description |
The increasing prevalence of metabolic syndrome-related diseases, including type-2 diabetes and obesity, makes it urgent to develop new alternative therapies, such as probiotics. In this study, we have used Caenorhabditis elegans under a high-glucose condition as a model to examine the potential probiotic activities of Pediococcusacidilactici CECT9879 (pA1c). The supplementation with pA1c reduced C. elegans fat accumulation in a nematode growth medium (NGM) and in a high-glucose (10 mM) NGM medium. Moreover, treatment with pA1c counteracted the effect of the high glucose by reducing reactive oxygen species by 20%, retarding the aging process and extending the nematode median survival (>2 days in comparison with untreated control worms). Gene expression analyses demonstrated that the probiotic metabolic syndrome-alleviating activities were mediated by modulation of the insulin/IGF-1 signaling pathway (IIS) through the reversion of the glucose-nuclear-localization of daf-16 and the overexpression of ins-6 and daf-16 mediators, increased expression of fatty acid (FA) peroxisomal β-oxidation genes, and downregulation of FA biosynthesis key genes. Taken together, our data suggest that pA1c could be considered a potential probiotic strain for the prevention of the metabolic syndrome-related disturbances and highlight the use of C. elegans as an appropriate in vivo model for the study of the mechanisms underlying these diseases. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2022-01-01 2022 2022-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/10171/116690 |
| url |
https://hdl.handle.net/10171/116690 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra instname:Universidad de Navarra |
| instname_str |
Universidad de Navarra |
| reponame_str |
Dadun. Depósito Académico Digital de la Universidad de Navarra |
| collection |
Dadun. Depósito Académico Digital de la Universidad de Navarra |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869406151301398528 |
| score |
15,811543 |